Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vestibular Schwannoma
Varian's RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
June 30th, 2009
Doctors in the Netherlands have developed new ways to perform radiosurgery on benign acoustic tumors using fast and precise RapidArc(TM) radiotherapy technology from Varian Medical Systems (NYSE:VAR). This is among the findings in several papers published by the team at VU University Medical Center in Amsterdam. Radiation oncologist Dr. Frank Lagerwaard and his team compared RapidArc with five-arc dynamic conformal arc radiosurgery for vestibular schwannoma, a benign tumor that affects hearing and balance. "Treatment delivery time after patient setup was less than five minutes versus 20 minutes for dynamic conformal arc radiosurgery," says Dr. Lagerwaard. "We found that...
Source: Cancer Weekly (2009-06-30)
|
